Bristol, PA, United States of America

Michael Kirkup


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Kirkup: Innovator in Pharmaceutical Chemistry

Introduction

Michael Kirkup is a notable inventor based in Bristol, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important compounds used in medical treatments. His innovative approach has led to the development of a unique method for synthesizing treprostinil and its derivatives.

Latest Patents

Kirkup holds a patent for a process titled "Process for the preparation of treprostinil and derivatives thereof." This patent describes a method that utilizes an easily scalable enzymatic resolution of a key intermediate for making these compounds. This method represents a significant improvement over prior art, particularly due to its regioselective Claisen rearrangement of a 5-allyloxy-benzaldehyde precursor, which is facilitated by a bromo substituent in the 2-position.

Career Highlights

Throughout his career, Michael Kirkup has demonstrated a commitment to advancing pharmaceutical science. His work at Scipharm Sarl has positioned him as a key player in the development of innovative drug synthesis methods. His contributions have not only enhanced the efficiency of drug production but have also improved the accessibility of essential medications.

Collaborations

Kirkup has collaborated with several talented individuals in his field, including Nareshkumar Jain and Michael A Marella. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael Kirkup's inventive spirit and dedication to pharmaceutical chemistry have led to significant advancements in drug synthesis. His patented methods for preparing treprostinil and its derivatives exemplify his commitment to improving medical treatments. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…